Neha Verma, MD
Neha Verma, MD
Specialty: Internal Medicine
Program: Internal and Hospital Medicine
Language(s): English
-
Overview
Dr. Neha Verma is an Assistant Member in the Moffitt Cancer Center Department of Internal Medicine, Internal and Hospital Medicine Program. Dr. Verma graduated with honors in Biochemistry from Case Western Reserve University and received her MD from Ross University School of Medicine. After receiving her medical degree, Dr. Verma completed an Internal Medicine Residency at Mount Sinai Hospital, Chicago. Before joining Moffitt, Dr. Verma most recently was a hospitalist at Northwestern Memorial Feinberg Hospital Chicago, IL. Dr. Verma teaches a variety of students and trainees. In her first year, the USF Internal Medicine residents awarded her the Golden Apple Recognition Award. Dr. Verma’s research interests are in immune-mediated adverse effects from immunotherapy agents. She is PI for a retrospective study titled “Neurologic Complications of Immune Checkpoint Inhibitors,” which aims to evaluate the clinical experience with neurologic toxicity. Her contributions have led to her being profiled in the “Women in Oncology at Moffitt” magazine. Dr Verma’s clinical interests include treating oncologic emergencies from spinal cord compression, tumor lysis syndrome, hypercalcemia of malignancy, neutropenic fever, and superior vena cava syndrome.
Education & Training
Residency:
- Mount Sinai Hospital - Internal Medicine
Medical School:
- Ross University School of Medicine - MD
-
Participating Trials
Clinical Trial 23294
Evaluation of Patient Outcomes with Implementation of an Immunotherapy Toxicity Service (iTOX) in an Acute Care Setting Prospective and Retrospective Study
Condition: Multiple
Status: OpenIf you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775. -
Publications
- Verma N, Jaffer MH, Kolli AS, Mokhtari S. Updates in the Management of Paraneoplastic Syndrome. Semin Neurol. 2024 Feb.44(1):36-46. Pubmedid: 38183975.
- Poovathukaran Babu A, Kis B, Patrick J, Verma N. Partial Splenic Artery Embolization in the Management of Acute Immune Thrombocytopenia Refractory to Medical Treatment. Ann Intern Med Clin Cases. 2023 Mar.
- Patrick J, Babu A, Verma N. An Unusual Presentation of Cryoglobulinemia in a Patient With Undiagnosed Sjögren's Syndrome and Treated Marginal Zone Lymphoma. Cureus. 2022 Dec.14(12):e32730. Pubmedid: 36686139. Pmcid: PMC9851851.
- Hembree T, Theou O, Thirlwell S, Reich RR, Cao B, Sehovic M, Syed M, Verma N, Nguyen TC, Keerty D, Wesolow J, Koverzhenko V, Extermann M, Huang J, Ramsakal A. A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study. Cancer Med. 2021 Sep.10(17):5765-5774. Pubmedid: 34350715. Pmcid: PMC8419777.
- Seok K, Hallanger-Johnson J, Holmstrom B, Hembree T, Sharda E, Ramsakal A, Verma N. Literally Malignant Hypertension. SN Compr Clin Med. 2021 May.3:1960-1964.
- Verma N, Jaffer M, Pina Y, Peguero E, Mokhtari S. Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 2021 Jul.13(7):e16337. Pubmedid: 34395120. Pmcid: PMC8357079.
- Shareef N, Verma N, Syed M. Strongyloides hyperinfection syndrome. Postgrad Med J. 2021 Jan. Pubmedid: 33452142.
- Jaffer M, Chung M, Sharda E, Ramsakal A, Peguero E, Verma N, Mokhtari S. Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. Clin Med Insights Oncol. 2020 Dec.14. Pubmedid: 33447124. Pmcid: PMC7780164.
- Chung M, Jaffer M, Verma N, Mokhtari S, Ramsakal A, Peguero E. Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange. J Neurol. 2020 Apr.267(4):1023-1025. Pubmedid: 31832829.
- Vanosdoll M, Ng N, Ho A, Wallingford A, Xu S, Matin SB, Verma N, Farzin A, Golden WC, Yazdi Y, Waiswa P, Labrique A, Acharya S. A Novel Mobile Health Tool for Home-Based Identification of Neonatal Illness in Uganda: Formative Usability Study. JMIR Mhealth Uhealth. 2019 Aug.7(8):e14540. Pubmedid: 31418428. Pmcid: PMC6714500.
-
Patient Comments
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments